Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 15/20 | 0.63 |
| ▸ | LCP2 | Q13094 | 4/20 | 0.63 |
| ▸ | RPS6KA2 | Q15349 | 3/20 | 0.63 |
| ▸ | PRKD2 | Q9BZL6 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29261243 | 1.00 | MAP4K1 (0.63) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261201 | 0.92 | LCP2 (0.62) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261286 | 0.92 | LCP2 (0.62) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261383 | 0.91 | LCP2 (0.56) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261381 | 0.91 | LCP2 (0.56) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261282 | 0.88 | MAP4K1 (0.72) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL25099593 | 0.88 | MAP4K1 (0.81) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL30233159 | 0.88 | MAP4K1 (0.81) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL30233150 | 0.87 | MAP4K1 (0.64) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261232 | 0.85 | MAP4K1 (0.69) | MAP4K1LCP2RPS6KA2PRKD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103369-A | Pyridolactam derivatives, preparation method and application thereof | 浙江海正药业股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023030478-A1 | PYRIDOLACTAM DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 浙江海正药业股份有限公司 | 2023-03-09 | — | — | WO | disclosed |